Table 3.
Male Participants |
Female Participants |
|||||||
MZ |
DZ |
MZ |
DZ |
|||||
Index | Twin | Co-Twin | Twin | Co-Twin | Twin | Co-Twin | Twin | Co-Twin |
CMIM17 | 2.7*** | 3.0*** | 1.9*** | 1.6*** | 2.3*** | 2.2*** | 2.5*** | 0.5 |
CMIF10 | 1.9*** | 1.5** | 1.3** | 0.3 | 2.3*** | 2.4*** | 2.5*** | 1.4*** |
CMICMF5 | 2.1*** | 2.2*** | 1.8*** | 1.2** | 2.0*** | 1.9*** | 2.5*** | 1.6*** |
CMIMS12 | 1.9*** | 2.7*** | 1.7*** | 1.1** | 0.6 | 0.3 | 1.3*** | −0.8* |
CMIFS5 | 1.2* | 0.3 | 1.0* | −0.4 | 2.5*** | 2.9*** | 1.7*** | 0.9* |
Notes: Twin = life span and health are measured in the same persons (control procedure); Co-Twin = health status is measured in twins, whereas life span is measured in Co-Twins (primary procedure). Co-Twin denotes a second twin in the pair. Note that the minus sign in the table means that unhealthy individuals live longer than healthy individuals. MZ = monozygotic; DZ = dizygotic; CMI = comorbidity index.
*0.01 < p ≤ .05; **0.001 < p ≤ .01; ***p ≤ .001; other results are insignificant.